Mapping the Fade: fNIRS Alzheimer's Disease Functional Connectivity in the Prefrontal Cortex

Current methods for detecting cognitive decline often rely on subjective questionnaires or expensive, immobile imaging machinery. We wait for symptoms to scream before we listen. This paper attempts to bypass that delay. It deploys light—specifically functional near-infrared spectroscopy (fNIRS)—to observe the haemodynamic responses of the brain in real-time.

The research team focused on the prefrontal cortex (PFC). They measured how different brain regions talk to one another across three distinct groups: elderly individuals with normal cognition (NC), those with mild cognitive impairment (MCI), and patients with Alzheimer's disease (AD). The goal was precise. They sought to identify exactly when and where the signal drops.

Tracking fNIRS Alzheimer's Disease Functional Connectivity

The findings offer a granular look at neural decay. The study measured functional connectivity (FC) strength between specific Brodmann areas (BA). Significant reductions appeared in the left dorsolateral PFC, specifically involving BA46.L and BA9.L. These areas are command centres for executive function. When they go quiet, cognition falters.

Time matters. The data shows distinct temporal signatures for each stage of decline. Between the normal and MCI groups, the most dramatic difference in connectivity strength occurred at the two-minute mark in region BA45.R. In contrast, the gap between MCI and Alzheimer's patients peaked later, at the five-minute mark in region BA1.L. The brain struggles to maintain connection the longer it works.

The researchers also correlated these biological signals with clinical reality. We see a negative correlation between FC strength in the BA46.L-BA45.R pair and scores on the Neuropsychiatric Inventory and Clinical Dementia Rating. This suggests that as the physical connection weakens, the clinical severity of dementia intensifies.

This is not just an academic exercise. It points toward a future where a simple, non-invasive headset could screen for these specific signal drops during a routine check-up. The technology is portable. The data is specific. By identifying these biomarkers now, we may eventually intervene before the network goes dark.